Gallas S, Drouineau J, Gabrillargues J, Pasco A, Cognard C, Pierot L, Herbreteau D
Department of Neuroradiology Hospitalier Universitaire Maison Blanche, Reims, France.
AJNR Am J Neuroradiol. 2008 Jan;29(1):63-8. doi: 10.3174/ajnr.A0757. Epub 2007 Oct 9.
The purpose of our study was to evaluate the technical feasibility, morbidity and mortality, and durability of occlusion of unruptured aneurysms treated with Guglielmi detachable coils (GDCs) with a long-term follow-up.
Between January 1998 and January 2005, we treated 321 unruptured aneurysms with GDCs in 5 neuroradiologic institutions. During this period, 63% of unruptured aneurysms were treated by endovascular technique. Procedural feasibility, technical complications, morbidity and mortality, and acute and long-term angiographic occlusion were assessed.
Overall technical feasibility of coiling treatment was 94%; 302 aneurysms were treated by endovascular technique. At the end of the initial procedure, acute occlusion was classified as complete in 207 cases (70%), subtotal in 84 cases (26.1%), and incomplete in 11 cases (3.9%). Ischemic complications were observed in 28 patients (9%); 8 patients (2.6%) had perforation of their aneurysms. Treatment-related morbidity was 14.4%, and morbidity with clinical complications was evaluated at 7.7% (n = 23 patients). Five patients (1.7%) died as a result of aneurysm perforation. Final follow-up angiograms, after 9 secondary treatments, demonstrated complete occlusion in 193 patients (69.5%), subtotal in 80 aneurysms (28.5%), and incomplete occlusion in 5 (1.8%). Nineteen patients were lost to follow-up (6.3%).
Endovascular coiling with detachable coils is an attractive option for treatment of unruptured aneurysms. This method of treatment is safe with a low rate of complications. Prospective studies with longer follow-up periods are needed to assess the long-term durability of occlusion in unruptured aneurysms.
我们研究的目的是通过长期随访评估使用 Guglielmi 可解脱弹簧圈(GDC)治疗未破裂动脉瘤的技术可行性、发病率和死亡率以及闭塞的持久性。
1998 年 1 月至 2005 年 1 月期间,我们在 5 家神经放射学机构用 GDC 治疗了 321 例未破裂动脉瘤。在此期间,63%的未破裂动脉瘤采用血管内技术治疗。评估了手术可行性、技术并发症、发病率和死亡率以及急性和长期血管造影闭塞情况。
弹簧圈栓塞治疗的总体技术可行性为 94%;302 个动脉瘤采用血管内技术治疗。在初始手术结束时,急性闭塞被分类为完全闭塞 207 例(70%),次全闭塞 84 例(26.1%),不完全闭塞 11 例(3.9%)。28 例患者(9%)出现缺血性并发症;8 例患者(2.6%)动脉瘤穿孔。与治疗相关的发病率为 14.4%,有临床并发症的发病率评估为 7.7%(n = 23 例患者)。5 例患者(1.7%)因动脉瘤穿孔死亡。9 次二次治疗后的最终随访血管造影显示,193 例患者(69.5%)完全闭塞,80 个动脉瘤(28.5%)次全闭塞,5 例(1.8%)不完全闭塞。19 例患者失访(6.3%)。
使用可解脱弹簧圈进行血管内栓塞是治疗未破裂动脉瘤的一种有吸引力的选择。这种治疗方法安全,并发症发生率低。需要进行更长随访期的前瞻性研究来评估未破裂动脉瘤闭塞的长期持久性。